ME

Meriyam Eruvasseri Kunhammed

Active Director Designated Partner DIN 11210093
DIN 11210093 First appointment Jul 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Meriyam Eruvasseri Kunhammed

Data last updated:

Meriyam Eruvasseri Kunhammed is a Designated Partner at Remex Medical Centre Llp (since 2025) and Designated Partner at Redolent Global Llp (since 2025). The companies operate in Healthcare.

DIN 11210093
Primary Designation Designated Partner
Industry Healthcare
First Appointment 17 Jul 2025
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 Jul 20252021Active
Designated Partner17 Jul 20252024Active

Board colleagues of Meriyam Eruvasseri Kunhammed

NameDINCompanyDesignation
Riyas Koovil09753167Remex Medical Centre Llp , Redolent Global LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Remex Medical Centre Llp
Redolent Global Llp
Premium access

Shareholding and investment profile for Meriyam Eruvasseri Kunhammed

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meriyam Eruvasseri Kunhammed

Meriyam Eruvasseri Kunhammed currently holds 2 directorships: Remex Medical Centre Llp (Designated Partner, since 21 Jul 2025); Redolent Global Llp (Designated Partner, since 17 Jul 2025).

Meriyam Eruvasseri Kunhammed was first appointed on 17 Jul 2025 as Designated Partner at Redolent Global Llp.

The current boards of Meriyam Eruvasseri Kunhammed's companies include Riyas Koovil (Remex Medical Centre Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available